DURABLE VACCINES. GLOBAL ACCESS.
What Industry Leaders (Key Decision Makers) Say
"mRNA instability is the #1 problem in the mRNA-based pharmaceuticals industry"
VISION
We’re Changing the Way the World Thinks About mRNA
Our innovative approach allows us to get more mRNA-based medicines into people's arms than ever before. By eliminating the need for cold chain infrastructure, we significantly improve the shelf-life of mRNA medicines.
Join us in revolutionizing the future of medicine.
Total Funding received: $460,000
Our
Partners
A $275,000 Small Business Technology Transfer (STTR) grant was received from NSF. A $110,000 Translational Research Grant (TRG) and a $10,000 NCBiotech Challenge Regional Finalist award was received from NCBC. A $50,000 sum was received from NSF National I-Corps program. A $15,000 TRG was received from UNCW. 5 hours of grant writing support was received from FFVC.
National Science Foundation (NSF)
University of North Carolina Wilmington (UNCW)
North Carolina Biotechnology Center (NCBC)
First Flight Venture Center (FFVC)
CAREERS
We’re looking for innovative and experienced talent to join our advisory board!
